Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody (Q43593354)

From Wikidata
Jump to navigation Jump to search
scientific article published in March 2001
edit
Language Label Description Also known as
English
Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody
scientific article published in March 2001

    Statements

    Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody (English)
    Garrity ER Jr
    Villanueva J
    Bhorade SM
    Husain AN
    Vigneswaran WT
    1 March 2001
    773-777

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit